Skip to content
  • Igi logo small 01IGI
  • GLOBAL PRESENCE
    • USUS Flag
    • INDIAIndia FLag
    • EUROPE
    • LATIN AMERICA
    • ROW
      • ASIA
        • MALAYSIA
      • AUSTRALIA
      • ME & Africa
      • RUSSIA & CIS
  • CONTACT US
  • FOLLOW USLinkedin
Instagram
glenmark-logo
  • ABOUT US
    • ABOUT US

      ABOUT US

      Evolution

      The achievements that highlight our journey

      Executive Team

      The team who translates vision into reality

      Governance

      The tenets of our functioning

      Awards

      Striving for Excellence

      Board of Directors

      The people who pave the way for a new world

  • INNOVATION
    • Our Innovation

      INNOVATION

      Our Innovation Journey
      Centres of Innovation
      Pipeline
  • PRODUCTS
    • Products

      PRODUCTS

      • Overview
      • Therapy Areas
      Global Presence +

      – USA
      – India
      – Europe
      – Latin America
      –  Row
          * Asia
          * Africa
          * Russia and CIS

      • Quality at Glenmark
      • Manufacturing Facilities
      • Business Development
  • RESPONSIBILITY
    • Responsibility

      RESPONSIBILITY

      Our Communities

      Enriching lives for a healthier and
      happier world

      • Child Health
      • Access to Health Care
      • Promotion of Sports
      • Sustainable Livelihoods
      • Glenmark Joy of Giving
      • Water Conservation and Mgmt
      • Impact Accessment Reports
      • Support during Covid-19
      Our Planet

      Operating responsibly towards a greener
      planet

      • Our Policy
      • Our Commitment
      • Our Initiative and Impact
      Reports

      Our Sustainability Reports

      • FY 2024
      • FY 2023
      • FY 2022
      • More
      Our People

      The people who pave the way for a new world

      • Equal Opportunity for all
      • Employee Health and Safety
      Foundations

      Spearheading our social initiatives

      • Glenmark Foundation
      • Glenmark Aquatic Foundation
  • INVESTORS
    • Investors

      INVESTORS

      Reports and Presentations
      Performance in numbers
      Shareholders Corner
      Be a part of the new world
      Latest Announcements
      For Investors and Shareholders
      ESG Profile
      Our Environment, Social & Governance initiatives
      Financial Results
      Growing from strength to strength
      Disclosures under Regulation 46

      Pursuant to SEBI LODR

      INVESTORS

      Latest Announcements
      For Investors and Shareholders
      Reports and Presentations
      Performance in numbers
      Financial Results
      Growing from strength to strength
      ESG Profile
      Our Environment, Social & Governance initiatives
      Shareholders Corner
      Be a part of the new world
      Disclosures under Regulation 46

      Pursuant to SEBI LODR

  • CAREERS
    • Careers

      CAREERS

      Life at Glenmark
      Join Us

        CAUTION NOTICE REGARDING FRAUDULENT RECRUITMENT

      This is to notify to the public that certain unscrupulous persons, purporting to be part of and/or being authorised by the human resources department of Glenmark Pharmaceuticals Limited (“Glenmark”) are fraudulently offering jobs via certain websites/or through telephone calls, SMS or fake letters and asking the prospective job aspirants to appear for a face-to-face interview for a job opening with Glenmark and/or to pay a fee for securing a job with Glenmark. We wish to caution the public that Glenmark does not collect any monies or any other valuables as a pre or post-employment requirement.


      Click Here to Know More        Click Here to Join Us

  • MEDIA
    • Media

      MEDIA

      Newsroom

      Latest and archived press releases

      Library

      Resources and information

  • Toggle website search
Menu Close
  • ABOUT US
    • Overview
    • Evolution
    • Governance
    • Board of Directors
    • Executive Team
    • Awards
  • INNOVATION
    • Overview
    • R&D
    • R&D Centres
    • R&D Pipeline
  • RESPONSIBILITY
    • Child Health
    • Access to Healthcare
    • Promotion of Sports
    • Sustainable Livelihoods
    • Glenmark Joy of Giving
    • Impact Assessment Report
    • Our Policy
    • Our Commitment
    • Our Initiative and Impact
    • Equal Opportunity for All
    • Employee Health and Safety
    • Reports
      • FY 2024
      • FY 2023
      • FY 2022
      • FY 2021
      • FY 2020
      • FY 2019
      • FY 2018
      • FY 2017
      • FY 2016
      • FY 2015
      • FY 2014
      • FY 2013
      • FY 2012
      • FY 2011
  • PRODUCTS
    • Product Overview
    • Formulations Overview
    • Global Presence
      • US
      • India
      • Europe
      • Latin America
      • ROW
        • Asia
        • ME & Africa
        • Russia & CIS
    • Quality at Glenmark
    • Manufacturing Facilities
    • Business Development
  • INVESTORS
    • Latest Announcements
    • Financial Result
    • Shareholders Corner
    • Reports & Presentations
    • ESG Profile
    • Disclosure under Regulation 46 of SEBI
  • CAREERS
    • Life at Glenmark
    • Join Us
  • MEDIA
    • Newsroom
  • GLENMARK WEBSITE
    • Glenmark Life Science
  • GLOBAL PRESENCE
    • USUS Flag
    • IndiaIndia FLag
    • Europe
    • Latin America
    • Row
      • Asia
        • Malaysia
      • Africa
      • Russia & CIS
America Banner
  1. Home>
  2. Product Overview>
  3. Colombia

Glenmark Colombia

CONTACT :

Para informar un evento adverso, envíe un correo electrónico a Farmacovigilancia.Colombia@glenmarkpharma.com
  • ABOUT US
  • RESPONSIBILITY
  • PRODUCTS
  • INVESTORS
  • CAREERS
  • MEDIA
  • CONTACT US
  • TERMS AND CONDITIONS
  • REPORT A CONCERN
  • PRIVACY PORTAL

© 2025 GLENMARK PHARMACEUTICALS LTD. ALL RIGHTS RESERVED